2023年2月27日～2023年3月5日の間に収集した論文情報を追加しました。(2/4)
①An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 through September 2021.
クラトムの安全性シグナル研究
対象DB：FAERS
②A retrospective study of adverse drug events in anticoagulant administration with relevance to COVID-19.
抗凝固剤における有害事象、COVID-19患者への適応についての研究
対象DB：FAERS
③Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database.
エミシズマブの潜在的な有害事象シグナルについての研究
対象DB：FAERS
④Gene Expression Profile as a Predictor of Seizure Liability.
薬剤誘発性発作の予測研究
対象DB：FAERS
⑤Electrolyte Disorders Associated with Piperacillin/Tazobactam: A Pharmacovigilance Study Using the FAERS Database.
ピペラシリン-タゾバクタムと電解質異常の関連性評価研究
対象DB：FAERS
⑥Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis.
多汗症治療薬の候補となる薬剤特定研究
対象DB：FAERS
⑦Vaccine confidence among those living with allergy during the COVID pandemic (ACCORD): A scoping review.
COVID-19ワクチン接種の躊躇とアレルギー反応に関する学術文献のレビュー研究
対象DB：VAERS